MB
Mark Brody
Member of Clinical Advisory BoardMark Brody M.D serves as Member of Clinical Advisory Board at IRulya Therapeutics Inc. (formerly known as Quince Therapeutics, Inc.) (formerly known as Cortexyme, Inc.).
Positions
- Company NameIRulya Therapeutics Inc.Stock CodeIRLAPositionMember of Clinical Advisory BoardColleagues
- BRBrigette RobertsCEO, Principal Executive Officer & Director
- JCJohn C. MilitelloCFO, Principal Financial Officer & Principal Accounting Officer
- KRKeith R. FandrickChief Operating Officer
- GRGuenter R. JanhoferChief Scientific Officer
- PBPaul B. YuChairman of Scientific Advisory Board
- LDLeone D. PattersonDirector
- JPJames P. ValentineDirector
